Pharma Pack from Burgopak Selected by Sanofi Aventis
Award-winning packaging design company Burgopak has strengthened its presence in the pharmaceutical industry after its pharmaceutical pack was selected for two product launches last month by Sanofi Aventis.
In 2008 the first automated Burgopak design was launched into the pharmaceutical market, offering companies a unique operating system that supports patient safety, is robust, portable and user-friendly. These innovative pharmaceutical packs incorporate Burgopak’s patented sliding mechanism, keeping the patient information booklet, blisters and branded outer carton conveniently connected at all times.
GP and Medical expert Dr. Mike Smith said: “The most important thing for GPs and pharmacists when it comes to pharmaceutical packaging is that it is supportive of patient safety and carries all the relevant information about the product. The Burgopak design is extremely patient safe as it virtually forces patients to keep their information booklet together with their pharmaceuticals. On top of this, Burgopak’s packaging is portable, easy to use and looks attractive. It really does give Sanofi Aventis’ products an edge over its competitors.”
Sanofi Aventis is the second international pharmaceutical company to recognise the benefits of the Burgopak design on their products. It will be used to package Sanofi Aventis’ painkiller DolipraneLib, and heartburn relief medication Maalox maux d’estomac, in France.
The Burgopak design has won top compliance packaging awards in the US and Europe, including Best Compliance Package (Pharmapack Paris, 2008), Best Pharmaceutical Pack (The Packaging Society — Silver, 2007) and Compliance Package of the Year (Healthcare Compliance Packaging Council, 2006).